Table 1.
The top 10 most significant GO terms of the overlapping DEGs.
| Category | GO Name | P-value | Genes |
|---|---|---|---|
| BP | Regulation of transcription from RNA polymerase II promoter | 6.25×10−3 | MDFI, KAT2A, CBX4, NUFIP1, LEF1, PDX1, PPARGC1A, BRCA1, TARBP1, LIF, INHBA, GTF2F2, NKX2-5, TWIST1, ALX1 |
| BP | Regionalization | 9.20×10−3 | MDFI, KAT2A, HOXC13, TBX20, LEF1, EN1, ALX1 |
| BP | Regulation of striated muscle tissue development | 0.0105 | BCL2, LEF1, NKX2-5, TWIST1 |
| BP | Chordate embryonic development | 0.0107 | KAT2A, TBX15, LEF1, EN1, HOXD1, NKX2-5, BRCA1, TWIST1, ALX1 |
| BP | Pattern specification process | 0.0110 | MDFI, KAT2A, HOXC13, TBX20, LEF1, EN1, GRHL3, ALX1 |
| BP | Regulation of muscle development | 0.0111 | BCL2, LEF1, NKX2-5, TWIST1 |
| BP | Embryonic development ending in birth or egg hatching | 0.0112 | KAT2A, TBX15, LEF1, EN1, HOXD1, NKX2-5, BRCA1, TWIST1, ALX1 |
| BP | Positive regulation of transcription, DNA-dependent | 0.0116 | LIF, INHBA, GTF2F2, TBX20, NUFIP1, LEF1, PDX1, PPARGC1A, NKX2-5, BRCA1, ALX1 |
| MF | Neurotransmitter receptor activity | 0.0119 | GABRD, ANXA9, SSTR1, CHRNA6, NPFFR1 |
| BP | Positive regulation of RNA metabolic process | 0.0123 | LIF, INHBA, GTF2F2, TBX20, NUFIP1, LEF1, PDX1, PPARGC1A, NKX2-5, BRCA1, ALX1 |
BP – biological process; MF – molecular function.